Anamorelin
ONO-7643 · RC-1291
An orally administered ghrelin receptor agonist studied in trials for cancer-related anorexia and cachexia. Not FDA approved.
Tracking and educational reference only, on values you enter yourself. Not medical advice or a dosing recommendation.
Half-life
Not established in a public source. Half-life is an educational pharmacology figure, drawn from public sources, and is not a schedule or dosing instruction.
Storage & handling
Investigational; no approved label defines handling.
References
- PubChem compound record
- Expert Opin Pharmacother 2015: anamorelin hydrochloride in cancer anorexia-cachexia
- Clin Pharmacol Drug Dev 2015: age and gender effects on pharmacokinetics
Read the source
Related in Growth Hormone
Educational reference only, compiled from public sources. Not medical advice, diagnosis, treatment, or a dosing recommendation, and not a recommendation to use any compound. Many compounds listed are research materials not approved for human use. Consult a qualified professional.